» Articles » PMID: 37296035

Hedgehog Signalling in Allograft Vasculopathy: a New Therapeutic Target?

Overview
Specialty Pharmacology
Date 2023 Jun 9
PMID 37296035
Authors
Affiliations
Soon will be listed here.
Abstract

Allograft vasculopathy (AV) leads to chronic rejection of organ transplants, but its causes are obscure. New research from the Jane-Wit laboratory showed that Sonic Hedgehog (SHH) signalling from damaged graft endothelium drives vasculopathy by promoting proinflammatory cytokine production and NLRP3-inflammasome activation in alloreactive CD4PTCH1PD-1T memory cells, offering new diagnostic and therapeutic strategies.

References
1.
Fang C, Manes T, Liu L, Liu K, Qin L, Li G . ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes. Nat Commun. 2019; 10(1):2247. PMC: 6529429. DOI: 10.1038/s41467-019-10041-2. View

2.
Pober J, Chih S, Kobashigawa J, Madsen J, Tellides G . Cardiac allograft vasculopathy: current review and future research directions. Cardiovasc Res. 2021; 117(13):2624-2638. PMC: 8783389. DOI: 10.1093/cvr/cvab259. View

3.
Cortes J, Gutzmer R, Kieran M, Solomon J . Hedgehog signaling inhibitors in solid and hematological cancers. Cancer Treat Rev. 2019; 76:41-50. DOI: 10.1016/j.ctrv.2019.04.005. View

4.
Yanez D, Papaioannou E, Chawda M, Rowell J, Ross S, Lau C . Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease. Front Immunol. 2021; 12:737245. PMC: 8463265. DOI: 10.3389/fimmu.2021.737245. View

5.
Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M . Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019; 129(8):3153-3170. PMC: 6668675. DOI: 10.1172/JCI125170. View